Stephanie Lang discusses a clinical trial investigating the use of TrueBeam to deliver hyperfractionated treatment to small tumours in the brain and lung. TrueBeam is a new radiosurgery technology that can image patients and deliver a dose of radiation to large or small tumours very quickly and accurately. TrueBeam requires less operating technicians than traditional technologies and it is hoped it will successfully reduce the risk of secondary cancer.